0001611793-19-000001.txt : 20190822 0001611793-19-000001.hdr.sgml : 20190822 20190822110205 ACCESSION NUMBER: 0001611793-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190822 DATE AS OF CHANGE: 20190822 EFFECTIVENESS DATE: 20190822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONL Therapeutics, Inc. CENTRAL INDEX KEY: 0001611793 IRS NUMBER: 464627845 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-347166 FILM NUMBER: 191044632 BUSINESS ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 BUSINESS PHONE: 734-926-5530 MAIL ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 D 1 primary_doc.xml X0708 D LIVE 0001611793 ONL Therapeutics, Inc. 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 734-926-5530 DELAWARE None None Corporation true David Zacks 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Executive Officer Director Mark Hooper 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Director Christine Gibbons 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Director Felicia David-Visser 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Director David Esposito 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Executive Officer Director Biotechnology Decline to Disclose 06b false 2019-08-15 false true true true false 0 3000000 3000000 0 false 25 0 0 0 false ONL Therapeutics, Inc. David Esposito David Esposito CEO & President 2019-08-22